SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-129916
Filing Date
2016-06-28
Accepted
2016-06-28 17:10:08
Documents
1
Period of Report
2016-06-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4332
  Complete submission text file 0001209191-16-129916.txt   5920
Mailing Address 2601 FOURTH AVENUE SUITE 500 SEATTLE WA 98121
Business Address 2601 FOURTH AVENUE SUITE 500 SEATTLE WA 98121 (206) 801-2100
Cascadian Therapeutics, Inc. (Issuer) CIK: 0001412067 (see all company filings)

IRS No.: 260868560 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address C/O ARRAY BIOPHARMA INC. 3200 WALNUT STREET BOULDER CO 80301
Business Address
Fyfe Gwen A. (Reporting) CIK: 0001506217 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33882 | Film No.: 161736778